Menu

ReShape Lifesciences Inc. RSLS

Full chart Compare
Set alert

Price alert · RSLS

All alert types
3.92 0.00 (+0.00%)

At closeAug 14, 2025, 4:00 PM EDT

2.80 Day range 4.65
4.09 52-week range 29.00
YTD
-99.12%
1 year
-99.62%

Revenue & Expenses

Revenue by
Other Income → Expenses: $236.26KProduct → Revenue: $174.65KExpenses → Selling, General & Admin: $2.37MExpenses → Research & Development: $588.26KExpenses → Other Operating Expenses: $7.62MExpenses → Interest Expense: $146.64KGross Profit → Expenses: $218.77KRevenue → Gross Profit: $218.77KRevenue → Cost of Revenue: $100.94KLicense → Revenue: $116.90KNet Loss → Expenses: $10.26MRoyalty → Revenue: $28.17KOther Income$236.26KGross Profit$218.77KNet Loss$10.26MCost of Revenue$100.94KExpenses$10.72MSelling, General & Admin$2.37MResearch & Development$588.26KOther Operating Expenses$7.62MInterest Expense$146.64KRevenue$319.71KProduct$174.65KLicense$116.90KRoyalty$28.17K

Latest period ending Dec 31, 2024 · select a line to chart its full history

Annual income statement

RSLS annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
8.01M8.68M11.24M13.60M11.30M
8.01M8.68M11.24M13.60M11.30M
2.95M3.13M4.44M5.25M5.04M
5.06M5.55M6.80M8.35M6.26M
12.79M20.93M53.15M66.23M18.72M
1.80M2.31M2.54M2.37M3.50M
9.92M17.87M31.34M33.21M15.22M
-7.73M-15.38M-46.35M-57.88M-12.46M
39.00K52.00K-380.00K-274.00K-181.00K
-7.13M-11.39M-46.21M-63.15M-21.63M
-7.13M-11.39M-46.21M-63.15M-21.63M
-7.13M-11.39M-46.21M-63.15M-21.63M
-7.13M-11.39M-46.21M-63.15M-21.63M
-345.75-2,771.75-157,905.00-419,006.50-401,650.00
-345.75-2,771.75-157,905.00-419,006.50-401,650.00
-345.75-2,771.75-157,905.00-419,006.50-401,650.00
-7.09M-11.34M-46.48M-62.59M-19.76M
-7.09M-11.34M-46.48M-62.59M-19.76M
20.62K4.11K29315154
20.62K4.11K29315154